Should induction chemotherapy be considered for all patients with gastric cancer?

Authors: Hickish, T.F. and Cunningham, D.

Journal: European Journal of Surgical Oncology

Volume: 20

Issue: 2

Pages: 185-186

ISSN: 0748-7983

Abstract:

An overall response rate of 70% is reported with systemic chemotherapy in gastric cancer, with 13% complete responses. Systemic chemotherapy should now be considered for all patients with gastric cancer, but its use should be prudent and in the context of clinical trials.

Source: Scopus

Preferred by: Tamas Hickish

Should induction chemotherapy be considered for all patients with gastric cancer?

Authors: Hickish, T.F. and Cunningham, D.

Journal: Eur J Surg Oncol

Volume: 20

Issue: 2

Pages: 185-186

ISSN: 0748-7983

Abstract:

An overall response rate of 70% is reported with systemic chemotherapy in gastric cancer, with 13% complete responses. Systemic chemotherapy should now be considered for all patients with gastric cancer, but its use should be prudent and in the context of clinical trials.

Source: PubMed

Should induction chemotherapy be considered for all patients with gastric cancer?

Authors: Hickish, T.F. and Cunningham, D.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Volume: 20

Issue: 2

Pages: 185-186

eISSN: 1532-2157

ISSN: 0748-7983

Abstract:

An overall response rate of 70% is reported with systemic chemotherapy in gastric cancer, with 13% complete responses. Systemic chemotherapy should now be considered for all patients with gastric cancer, but its use should be prudent and in the context of clinical trials.

Source: Europe PubMed Central